Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.

Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.

Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.

View all videos

ASH 2020

American Society of Hematology (ASH) Annual Meeting and Exposition
05–08 December 2020

#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:

👉http://ow.ly/70he50KOSG1👈

#MPNsm #HemOnc #BloodCancerAwarenessMonth

We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:

🎥: http://ow.ly/ibfm50KOSf3

@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth

We're pleased to bring you another podcast! 🤩

Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.

🎧: http://ow.ly/2Top50KQC0l

#MMsm #HemOnc #ImmunoOnc

Join us this week in Houston, TX, as we interview experts & bring you exclusive discussions from #SOHO22! 👩‍⚕️👨‍⚕️

You won't want to miss out - follow us @VJHemOnc or visit http://VJHemOnc.com for more!

@SocietyofHemOnc #MMsm #LeuSM #AMLsm #ALLsm #LymSM #MDSsm #MPNsm #CLLsm

Load More...

ASH 2020

American Society of Hematology (ASH) Annual Meeting and Exposition
05–08 December 2020

Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.

Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.

Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.

View all videos

#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:

👉http://ow.ly/70he50KOSG1👈

#MPNsm #HemOnc #BloodCancerAwarenessMonth

We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:

🎥: http://ow.ly/ibfm50KOSf3

@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth

We're pleased to bring you another podcast! 🤩

Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.

🎧: http://ow.ly/2Top50KQC0l

#MMsm #HemOnc #ImmunoOnc

Join us this week in Houston, TX, as we interview experts & bring you exclusive discussions from #SOHO22! 👩‍⚕️👨‍⚕️

You won't want to miss out - follow us @VJHemOnc or visit http://VJHemOnc.com for more!

@SocietyofHemOnc #MMsm #LeuSM #AMLsm #ALLsm #LymSM #MDSsm #MPNsm #CLLsm

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter